Progyny (NASDAQ:PGNY) Issues Earnings Results
Progyny (NASDAQ:PGNY) Issues Earnings Results
Progyny (NASDAQ:PGNY – Get Rating) issued its quarterly earnings data on Thursday. The company reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.04, Briefing.com reports. Progyny had a net margin of 7.39% and a return on equity of 18.11%. The firm had revenue of $195.00 million for the quarter, compared to analyst estimates of $190.51 million. During the same quarter in the previous year, the business posted $0.19 EPS. The firm's revenue was up 51.5% compared to the same quarter last year.
納斯達克(股票代碼：PGNY-GET Rating)週四發佈了季度收益數據。據Briefing.com報道，該公司公佈本季度每股收益為0.09美元，比分析師普遍預期的0.05美元高出0.04美元。Progyny的淨利潤率為7.39%，股本回報率為18.11%。該公司本季度營收為1.95億美元，而分析師預期為1.9051億美元。在去年同一季度，該業務公佈的每股收益為0.19美元。與去年同期相比，該公司的收入增長了51.5%。
Progyny Price Performance
孕期性價比
Shares of PGNY stock opened at $41.15 on Friday. Progyny has a 12 month low of $25.67 and a 12 month high of $68.32. The firm has a market capitalization of $3.78 billion, a P/E ratio of 89.46, a P/E/G ratio of 21.71 and a beta of 1.85. The company's fifty day moving average price is $30.23 and its two-hundred day moving average price is $37.32.
上週五，PGNY股票開盤報41.15美元。Progyny的12個月低點為25.67美元，12個月高位為68.32美元。該公司的市值為37.8億美元，市盈率為89.46，市盈率為21.71，貝塔係數為1.85。該公司的50日移動均線價格為30.23美元，200日移動均線價格為37.32美元。
Insiders Place Their Bets
內部人士下注
In other Progyny news, Chairman David J. Schlanger sold 1,452 shares of the business's stock in a transaction on Monday, June 27th. The shares were sold at an average price of $31.21, for a total value of $45,316.92. Following the transaction, the chairman now owns 82,548 shares in the company, valued at approximately $2,576,323.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, Chairman David J. Schlanger sold 1,452 shares of the company's stock in a transaction dated Monday, June 27th. The shares were sold at an average price of $31.21, for a total value of $45,316.92. Following the sale, the chairman now owns 82,548 shares in the company, valued at approximately $2,576,323.08. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Norman Payson sold 6,618 shares of the company's stock in a transaction dated Wednesday, May 11th. The shares were sold at an average price of $33.45, for a total transaction of $221,372.10. Following the completion of the sale, the director now owns 490,828 shares in the company, valued at approximately $16,418,196.60. The disclosure for this sale can be found here. Insiders have sold 41,240 shares of company stock worth $1,291,601 in the last quarter. 14.00% of the stock is owned by corporate insiders.
在Progyny的其他消息中，董事長David J.Schlanger在6月27日星期一的一次交易中出售了1,452股該公司的股票。這些股票的平均價格為31.21美元，總價值為45316.92美元。交易完成後，董事長現在擁有該公司82,548股，價值約2,576,323.08美元。這筆交易是在提交給美國證券交易委員會(Securities&Exchange Commission)的一份文件中披露的，可以通過這個鏈接訪問。在其他新聞方面，董事長大衞·J·施蘭格在一筆日期為6月27日星期一的交易中出售了1,452股公司股票。這些股票的平均價格為31.21美元，總價值為45316.92美元。出售後，董事長現在擁有該公司82,548股，價值約2,576,323.08美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，可以通過美國證券交易委員會網站訪問該文件。此外，在一筆日期為5月11日(星期三)的交易中，董事諾曼·佩森出售了6618股該公司股票。這些股票的平均價格為33.45美元，總成交額為221,372.10美元。出售完成後，董事現在擁有該公司490,828股，價值約16,418,196.60美元。此次拍賣的披露信息可在此處找到。上個季度，內部人士出售了41,240股公司股票，價值1,291,601美元。14.00%的股份由企業內部人士持有。
Institutional Investors Weigh In On Progyny
機構投資者對Progyny的看法
About Progyny
關於Progyny
(Get Rating)
(獲取評級)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Progyny，Inc.是一家福利管理公司，專門為美國僱主提供生育和家庭建設福利解決方案。其生育福利解決方案包括差異化福利計劃設計、個性化禮賓式會員支持服務和有選擇的生育專家網絡。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It's Cheap
- 免費獲取StockNews.com關於Progyny的研究報告(PGNY)
- MarketBeat：回顧中的一週8/1-8/5
- 如何利用高貝塔係數股票最大化你的投資利潤
- 克羅諾斯集團(Cronos Group Inc.)營收上升，是時候收購了嗎？
- 蘋果為何可能在年底創下歷史新高
- Beyond Meat不是沒有希望，而且它很便宜
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.
接受Progyny Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Progyny和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。